About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
268 genotypes with 567 annotations displayed of selected term and subterms
Searched Term: abnormal prostate gland morphology
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Acp3tm1Pivi/Acp3tm1Pivi
(B6.Cg-Acp3tm1Pivi) 		abnormal prostate gland dorsolateral lobe morphology J:207558
abnormal prostate gland epithelium morphology J:207558
increased prostate gland adenocarcinoma incidence J:207558
increased prostate intraepithelial neoplasia incidence J:207558
prostate gland dorsolateral lobe hyperplasia J:207558
Ahrtm1Bra/Ahr+
Tg(TRAMP)8247Ng/0
(B6.Cg-Ahrtm1Bra Tg(TRAMP)8247Ng) 		increased prostate gland tumor incidence J:118152
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra) 		decreased prostate gland anterior lobe weight J:126176
decreased prostate gland dorsolateral lobe weight J:126176
Ahrtm1Bra/Ahrtm1Bra
Tg(TRAMP)8247Ng/0
(B6.Cg-Ahrtm1Bra Tg(TRAMP)8247Ng) 		increased prostate gland tumor incidence J:118152
Akap12tm1Ihg/Akap12tm1Ihg
(involves: 129S4/SvJae * C57BL/6) 		abnormal prostate gland morphology J:138882
increased prostate gland weight J:138882
prostate gland anterior lobe hyperplasia J:138882
prostate gland ventral lobe hyperplasia J:138882
Apctm1Tno/Apctm1Tno
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:120308
increased prostate intraepithelial neoplasia incidence J:120308
prostate gland epithelial hyperplasia J:120308
Artm1(AR)Dmr/Y
Tg(TRAMP)8247Ng/0
(involves: 129S1/Sv * C57BL/6) 		increased prostate gland tumor incidence J:108849
Artm1.1Chc/Y
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		absent prostate gland J:89886
Artm1.1Jdz/Y
(B6.129X1-Artm1.1Jdz) 		absent prostate gland J:123057
Artm1.1Jdz/Y
(involves: 129X1/SvJ * C57BL/6) 		absent prostate gland J:122327
Artm1Chc/Y
Tg(Pbsn-cre)4Prb/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		abnormal prostate gland epithelium morphology J:123402
abnormal prostate gland morphology J:123402
enlarged prostate gland ventral lobe J:123402
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		absent prostate gland J:81789
Artm1Fcl/Y
(involves: 129S2/SvPas * C57BL/6) 		decreased prostate gland anterior lobe weight J:120102
decreased prostate gland ventral lobe weight J:120102
Artm1Jdz/Y
Tg(Pbsn-cre)20Fwan/?
(involves: 129X1/SvJ * C57BL/6 * FVB/NCrl) 		abnormal prostate gland anterior lobe morphology J:122327
abnormal prostate gland epithelium morphology J:122327
abnormal prostate gland morphology J:122327
decreased prostate gland weight J:122327
small prostate gland J:122327
small prostate gland anterior lobe J:122327
small prostate gland ventral lobe J:122327
Artm1Ska/Y
Tg(CMV-cre)1Ipc/?
(involves: C57BL/6 * CBA) 		absent prostate gland J:85484
Artm1Verh/Y
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:172730
Artm2(AR)Dmr/Y
Tg(TRAMP)8247Ng/0
(involves: 129S1/Sv * C57BL/6) 		increased prostate gland tumor incidence J:108849
Artm3.1(AR)Ska/Y
(involves: C57BL/6 * C57BL/6J * CBA) 		decreased prostate gland weight J:170092
small prostate gland J:170092
Artm3.1(AR)Ska/Y
Tg(KLKB1-cre/ERT2)1Pcn/0
(involves: C57BL/6 * C57BL/6J * CBA) 		increased prostate gland ventral lobe weight J:170092
increased prostate gland weight J:170092
Artm3.1(AR)Ska/Y
Tg(KLKB1-cre/ERT2)1Pcn/0
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * C57BL/6J * CBA) 		increased prostate gland tumor incidence J:170092
Atl3em1(IMPC)Tcp/Atl3em1(IMPC)Tcp
(C57BL/6N-Atl3em1(IMPC)Tcp/Tcp) 		enlarged prostate gland J:211773
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal prostate gland epithelium morphology J:54681
Bmp4tm1Blh/Bmp4+
(B6.129S2-Bmp4tm1Blh) 		abnormal prostate gland anterior lobe morphology J:42445
Braftm1Mmcm/Braftm1Mmcm
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Pten+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:191327
increased prostate gland tumor incidence J:191327
increased prostate intraepithelial neoplasia incidence J:191327
Brca2tm1Brn/Brca2tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:161511
prostate gland hyperplasia J:161511
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53+
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal prostate gland morphology J:161511
increased prostate intraepithelial neoplasia incidence J:161511
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:161511
prostate gland hyperplasia J:161511
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas) 		abnormal prostate gland dorsolateral lobe morphology J:115443
decreased prostate gland dorsolateral lobe weight J:115443
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas) 		decreased prostate gland anterior lobe weight J:115443
decreased prostate gland dorsolateral lobe weight J:115443
decreased prostate gland ventral lobe weight J:115443
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv) 		abnormal prostate gland dorsolateral lobe morphology J:115443
Cdkn1btm1Kin/Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged prostate gland J:33402
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Nkx3-1tm1.1Saa/Nkx3-1tm1.1Saa
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased prostate intraepithelial neoplasia incidence J:89571
Cdkn1ctm1Kat/Cdkn1ctm1Kat
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal prostate gland development J:61190
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(tetO-BRAF*V600E)29Lc/0
Tg(Tyr-rtTA)37Lc/0
(involves: 129/Sv * C57BL/6J * SJL) 		increased prostate gland adenocarcinoma incidence J:144358
prostate gland hyperplasia J:144358
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:222916
increased prostate gland tumor incidence J:222916
Cop1tm2.1Vmd/Cop1+
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
increased prostate intraepithelial neoplasia incidence J:172653
Cop1tm2.1Vmd/Cop1+
Tg(Pbsn-cre)4Prb/0
(B6N.Cg-Cop1tm2.1Vmd Tg(Pbsn-cre)4Prb) 		prostate gland hyperplasia J:172653
Cop1tm2.1Vmd/Cop1tm2.1Vmd
Tg(Pbsn-cre)4Prb/0
(B6N.Cg-Cop1tm2.1Vmd Tg(Pbsn-cre)4Prb) 		increased prostate intraepithelial neoplasia incidence J:172653
prostate gland hyperplasia J:172653
Ctnnb1tm1Mmt/Ctnnb1+
Igs2tm1(CAG-Met)Zsu/Igs2+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:284956
increased prostate intraepithelial neoplasia incidence J:284956
Ctnnb1tm1Mmt/Ctnnb1+
Krastm1Bbd/Kras+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland tumor incidence J:143034
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Pbsn-cre)4Prb/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034, J:284956
increased prostate intraepithelial neoplasia incidence J:143034, J:284956
Cyp11a1tm1Bcc/Cyp11a1tm1Bcc
(involves: 129 * C57BL/6) 		absent prostate gland J:78062
absent prostate gland anterior lobe J:78062
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6) 		enlarged prostate gland J:70204
increased prostate gland anterior lobe weight J:70204
increased prostate gland dorsolateral lobe weight J:70204
increased prostate gland ventral lobe weight J:70204
increased prostate gland weight J:48086, J:70204
prostate gland anterior lobe hyperplasia J:70204
prostate gland dorsolateral lobe hyperplasia J:70204
prostate gland hyperplasia J:70204
prostate gland ventral lobe hyperplasia J:70204
Del(6Ephb6-Trpv6)2Mfre/Del(6Ephb6-Trpv6)2Mfre
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) 		abnormal prostate gland duct morphology J:185629
abnormal prostate gland epithelium morphology J:185629
abnormal prostate gland morphology J:185629
Del(16Tmprss2-Erg)1Sho/Del(16Tmprss2-Erg)1Sho
(involves: C57BL/6 * DBA/2) 		prostate gland hyperplasia J:212219
Del(16Tmprss2-Erg)1Sho/Del(16Tmprss2-Erg)1Sho
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:212219
Dync1li1em1(IMPC)Tcp/Dync1li1+
(C57BL/6NCrl-Dync1li1em1(IMPC)Tcp/Tcp) 		enlarged prostate gland J:211773
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow
Eaf2tm1Zhow/Eaf2tm1Zhow
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:288972
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow
Tg(Pbsn-cre)4Prb/0
(B6(Cg)-Eaf1tm1.1Zhow Tg(Pbsn-cre)4Prb) 		increased prostate intraepithelial neoplasia incidence J:288972
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal prostate gland epithelium morphology J:145228
abnormal prostate gland morphology J:145228
increased prostate gland weight J:145228
increased prostate intraepithelial neoplasia incidence J:145228
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd) 		increased prostate intraepithelial neoplasia incidence J:288972
Egr1tm1Jmi/Egr1tm1Jmi
Tg(Defcr2-TAg)#Jig/?
(involves: 129 * C57BL/6 * FVB/N) 		decreased prostate gland tumor incidence J:67125
Egr1tm1Pch/Egr1tm1Pch
(involves: 129S2/SvPas * C57BL/6J) 		small prostate gland J:45064
Eif2ak3tm1.2Drc/Eif2ak3tm1.2Drc
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-MYC,-GFP*)#Rugg/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2) 		decreased prostate gland tumor incidence J:261540
Elac2em1Afi/Elac2em1Afi
(C57BL/6N-Elac2em1Afi) 		abnormal prostate gland anterior lobe morphology J:336403
abnormal prostate gland dorsolateral lobe morphology J:336403
prostate gland anterior lobe hyperplasia J:336403
prostate gland dorsolateral lobe hyperplasia J:336403
prostate gland hyperplasia J:336403
Elac2em1Afi/Elac2em1Afi
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * C57BL/6N) 		increased prostate intraepithelial neoplasia incidence J:336403
prostate gland hyperplasia J:336403
Ergtm1.1Sho/Ergtm1.1Sho
Ptentm1Hwu/Ptentm1Hwu
Tmprss2tm3Sho/Tmprss2tm3Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
Esr1tm1Syeh/Esr1tm1Syeh
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129X1/SvJ * FVB/N) 		abnormal prostate gland branching morphogenesis J:147000
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		prostate gland epithelial hyperplasia J:51663
Extl3em1(IMPC)Mbp/Extl3+
(C57BL/6N-Extl3em1(IMPC)Mbp/MbpMmucd) 		abnormal prostate gland morphology J:211773
Fem1btm1Mms/Fem1btm1Mms
(either: 129S6/SvEvTac-Fem1btm1Mms or (involves: 129S6/SvEvTac * C57BL/6)) 		decreased prostate gland duct number J:139640
Fgf10tm1Wss/Fgf10tm1Wss
(involves: 129X1/SvJ) 		abnormal prostate gland morphology J:85295
absent prostate gland J:85295
Fgfr2svs/Fgfr2svs
(involves: CXB5/ByJ) 		abnormal prostate gland branching morphogenesis J:82767
decreased prostate gland duct number J:82767
increased prostate gland weight J:82767
Fkbp4tm1Dvds/Fkbp4tm1Dvds
(involves: 129X1/SvJ * C57BL/6) 		abnormal prostate gland morphology J:98554
absent prostate gland anterior lobe J:98554
small prostate gland anterior lobe J:98554
Fkbp4tm1Shou/Fkbp4tm1Shou
(involves: 129S/SvEv) 		abnormal prostate gland development J:120960
Foxp3sf/Y
(involves: STOCK MR) 		absent prostate gland anterior lobe J:14076
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased prostate gland ventral lobe weight J:53777
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sor+
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased prostate gland adenocarcinoma incidence J:234601
increased prostate intraepithelial neoplasia incidence J:234601
Gt(ROSA)26Sortm1(CAG-AR)Zsu/Gt(ROSA)26Sortm1(CAG-AR)Zsu
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased prostate gland adenocarcinoma incidence J:234601
increased prostate intraepithelial neoplasia incidence J:234601
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Ptentm1Mro/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:184533
increased prostate intraepithelial neoplasia incidence J:184533
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		increased prostate intraepithelial neoplasia incidence J:184533
prostate gland hyperplasia J:184533
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Rb1tm2Brn/Rb1+
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland tumor incidence J:307910
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Rb1tm2Brn/Rb1tm2Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland tumor incidence J:307910
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:307910
Gt(ROSA)26Sortm1(CAG-PTPN1,-EGFP)Mtr/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:231906
prostate gland anterior lobe hyperplasia J:231906
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129S4/SvJae * BALB/c * C57BL/6) 		increased prostate gland tumor incidence J:130367
increased prostate intraepithelial neoplasia incidence J:130367
prostate gland hyperplasia J:130367
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		enlarged prostate gland anterior lobe J:170965
increased prostate gland tumor incidence J:170965
increased prostate gland weight J:170965
prostate gland hyperplasia J:170965
Gt(ROSA)26Sortm1(JAG1)Xin/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		abnormal prostate gland morphology J:238768
increased prostate gland adenocarcinoma incidence J:238768
increased prostate intraepithelial neoplasia incidence J:238768
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
increased prostate intraepithelial neoplasia incidence J:239660
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:239660
Gt(ROSA)26Sortm1(SPOP*F133V)Mrbn/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: C57BL/6 * DBA/2) 		abnormal prostate gland morphology J:239660
Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key/Gt(ROSA)26Sor+
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		prostate gland ventral lobe hyperplasia J:200002
Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key/Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		enlarged prostate gland J:200002
increased prostate gland adenocarcinoma incidence J:200002
increased prostate intraepithelial neoplasia incidence J:200002
Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key/Gt(ROSA)26Sortm1(TMPRSS2/ERG)Key
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		prostate gland ventral lobe hyperplasia J:200002
Gt(ROSA)26Sortm2(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		enlarged prostate gland anterior lobe J:170965
increased prostate gland tumor incidence J:170965
increased prostate gland weight J:170965
prostate gland hyperplasia J:170965
Hoxa10tm1Rilm/Hoxa10tm1Rilm
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6)) 		abnormal prostate gland anterior lobe morphology J:51967
decreased ductal branching in the coagulating gland J:51967
small prostate gland anterior lobe J:51967
Hoxa13Hd/Hoxa13+
(B6C3Fe-a/a Hoxa13Hd Mcoln3Va-J/J) 		abnormal prostate gland anterior lobe morphology J:54823
decreased prostate gland duct number J:54823
small prostate gland dorsolateral lobe J:54823
small prostate gland ventral lobe J:54823
Hoxb13tm1Mrc/Hoxb13tm1Mrc
(Not Specified) 		abnormal prostate gland ventral lobe morphology J:82540
Hoxb13tm1Mrc/Hoxb13tm1Mrc
Hoxd13tm1Mrc/Hoxd13tm1Mrc
(involves: 129S7/SvEvBrd) 		abnormal prostate gland ventral lobe morphology J:82540
Hoxb13tm2Mrc/Hoxb13tm2Mrc
(Not Specified) 		abnormal prostate gland ventral lobe morphology J:82540
Hoxb13tm2Mrc/Hoxb13tm2Mrc
Hoxd13tm1Mrc/Hoxd13tm1Mrc
(involves: 129S7/SvEvBrd) 		abnormal prostate gland ventral lobe morphology J:82540
Hprt1tm1(Pbsn*-cre/ERT2)Jir/Y
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:144357
increased prostate intraepithelial neoplasia incidence J:144357
Hpw1SEG/Pas/Hpw1SEG/Pas
(involves: C57BL/6J * SEG/Pas) 		increased prostate gland weight J:124156
Hsd17b3tm1.2Mpo/Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl) 		decreased prostate gland ventral lobe weight J:301756
Hspa5tm1Alee/Hspa5+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/?
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
increased prostate intraepithelial neoplasia incidence J:142106
Igs2tm1(CAG-Met)Zsu/Igs2+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2 * FVB/N) 		increased prostate gland adenocarcinoma incidence J:268934
increased prostate gland tumor incidence J:268934
increased prostate intraepithelial neoplasia incidence J:268934
Igs2tm1(CAG-Met)Zsu/Igs2+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N) 		increased prostate intraepithelial neoplasia incidence J:268934
Ing2tm1.1Ccha/Ing2tm1.1Ccha
(involves: 129 * C57BL/6J * FVB/N) 		abnormal prostate gland morphology J:167311
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae) 		decreased prostate gland weight J:181650
small prostate gland J:181650
Kiss1rtm1Coll/Kiss1rtm1Coll
(involves: 129S6/SvEvTac) 		absent prostate gland J:96442
Kiss1rtm1Gstn/Kiss1rtm1Gstn
(involves: 129P2/OlaHsd) 		absent prostate gland J:102113
Klf5tm1.1Jtd/Klf5+
Tg(Pbsn-cre)4Prb/0
(involves: C57BL/6 * DBA/2) 		abnormal prostate gland anterior lobe morphology J:206639
abnormal prostate gland dorsolateral lobe morphology J:206639
decreased prostate gland weight J:206639
prostate gland hyperplasia J:206639
Klf5tm1.1Jtd/Klf5tm1.1Jtd
Tg(Pbsn-cre)4Prb/0
(involves: C57BL/6 * DBA/2) 		decreased prostate gland weight J:206639
prostate gland hyperplasia J:206639
Klf6tm1Fjs/Klf6tm1Fjs
Nkx3-1tm3(cre)Mms/Nkx3-1+
(involves: 129/Sv * C57BL/6) 		abnormal prostate gland anterior lobe morphology J:153183
abnormal prostate gland branching morphogenesis J:153183
abnormal prostate gland duct morphology J:153183
Klrk1tm1Dhr/Klrk1tm1Dhr
Tg(TRAMP)8247Ng/?
(involves: C57BL/6 * CD-1) 		increased prostate gland tumor incidence J:134509
Krastm1Bbd/Kras+
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:143034
increased prostate intraepithelial neoplasia incidence J:143034
prostate gland hyperplasia J:143034
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		abnormal prostate gland morphology J:184935
increased prostate gland adenocarcinoma incidence J:184935
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scrib+
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:178461
increased prostate intraepithelial neoplasia incidence J:178461
Krastm4Tyj/Kras+
Scribtm1.1Phum/Scribtm1.1Phum
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:178461
increased prostate intraepithelial neoplasia incidence J:178461
prostate gland hyperplasia J:178461
Krastm4Tyj/Kras+
Tg(Pbsn-cre)20Fwan/0
(involves: 129S4/SvJae * FVB/NCrl) 		increased prostate intraepithelial neoplasia incidence J:178461
prostate gland hyperplasia J:178461
Ldahtm1Mrtn/Ldahtm1Mrtn
(CBACa.129S4(B6)-Ldahtm1Mrtn) 		increased prostate intraepithelial neoplasia incidence J:101977
Lhbtm1Kmr/Lhbtm1Kmr
(involves: 129S7/SvEvBrd * C57BL/6J) 		small prostate gland J:94719
Lhcgrtm1.1Pnara/Lhcgr+
(involves: 129S1/SvImJ * 129X1/SvJ * C57BL/6J) 		enlarged prostate gland J:203295
increased prostate gland weight J:203295
Lhcgrtm1Hht/Lhcgrtm1Hht
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal prostate gland morphology J:105533
prostate gland hypoplasia J:66818
small prostate gland anterior lobe J:105533
Lhcgrtm1Zmlei/Lhcgrtm1Zmlei
(either: 129X1/SvJ-Lhcgrtm1Zmlei or (involves: 129X1/SvJ * C57BL/6)) 		prostate gland hypoplasia J:66817
small prostate gland J:66817
Lhx3tm1.1Sjr/Lhx3tm1.1Sjr
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		small prostate gland J:169035
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(ARR2/Pbsn-MYC)7Key/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J) 		decreased prostate gland tumor incidence J:223213
increased prostate gland adenocarcinoma incidence J:223213
small prostate gland J:223213
Msmbtm1Xuan/Msmbtm1Xuan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		enlarged prostate gland dorsolateral lobe J:96884
enlarged prostate gland ventral lobe J:96884
increased prostate gland adenocarcinoma incidence J:96884
increased prostate intraepithelial neoplasia incidence J:96884
Mxi1tm1Rdp/Mxi1tm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		abnormal prostate gland morphology J:48236
prostate gland epithelial hyperplasia J:48236
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased prostate intraepithelial neoplasia incidence J:86563
Ncoa1tm1Bwo/Ncoa1tm1Bwo
(involves: 129/Sv * C57BL/6) 		small prostate gland J:46528
Nkx3-1tm1Hha/Nkx3-1+
(involves: 129S4/SvJae * C57BL/6) 		abnormal prostate gland anterior lobe morphology J:63764
prostate gland anterior lobe hyperplasia J:63764
prostate gland dorsolateral lobe hyperplasia J:63764
Nkx3-1tm1Hha/Nkx3-1tm1Hha
(involves: 129S4/SvJae * C57BL/6) 		abnormal prostate gland branching morphogenesis J:63764
abnormal prostate gland epithelium morphology J:63764
abnormal prostate gland morphology J:63764
decreased ductal branching in the coagulating gland J:63764
decreased prostate gland duct number J:63764
prostate gland anterior lobe hyperplasia J:63764
prostate gland dorsolateral lobe hyperplasia J:63764
small prostate gland anterior lobe J:63764
Nkx3-1tm1Mms/Nkx3-1+
(either: (involves: 129S1/Sv * 129S1/SvImJ) or (involves: 129S1/Sv * 129S1/SvImJ * C57BL/6J)) 		abnormal prostate gland epithelium morphology J:54465
prostate gland anterior lobe hyperplasia J:54465
prostate gland epithelial hyperplasia J:54465
Nkx3-1tm1Mms/Nkx3-1+
Ptentm1Rps/Pten+
(involves: 129S1/Sv * 129S1/SvImJ * C57BL/6J) 		increased prostate gland tumor incidence J:75085
increased prostate intraepithelial neoplasia incidence J:75085
Nkx3-1tm1Mms/Nkx3-1tm1Mms
(either: (involves: 129S1/Sv * 129S1/SvImJ) or (involves: 129S1/Sv * 129S1/SvImJ * C57BL/6J)) 		abnormal prostate gland anterior lobe morphology J:54465
abnormal prostate gland branching morphogenesis J:54465
abnormal prostate gland epithelium morphology J:54465
decreased prostate gland duct number J:54465
prostate gland anterior lobe hyperplasia J:54465
prostate gland dorsolateral lobe hyperplasia J:54465
prostate gland epithelial hyperplasia J:54465
Nkx3-1tm1Mms/Nkx3-1tm1Mms
(involves: 129S1/Sv) 		increased prostate intraepithelial neoplasia incidence J:131932
Nkx3-1tm1Mms/Nkx3-1tm1Mms
Ptentm1Rps/Pten+
(involves: 129S1/Sv * 129S1/SvImJ * C57BL/6J) 		increased prostate gland tumor incidence J:75085
increased prostate intraepithelial neoplasia incidence J:75085
Nkx3-1tm1Saa/Nkx3-1tm1Saa
Tg(KLK3-cre)13Saa/?
(involves: C57BL/6) 		increased prostate intraepithelial neoplasia incidence J:74350
Nkx3-1tm1Siz/Nkx3-1tm1Siz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal prostate gland anterior lobe morphology J:64981
abnormal prostate gland epithelium morphology J:64981
abnormal prostate gland morphology J:64981
decreased ductal branching in the coagulating gland J:64981
decreased prostate gland duct number J:64981
prostate gland epithelial hyperplasia J:64981
prostate gland lateral lobe hypoplasia J:64981
small prostate gland anterior lobe J:64981
small prostate gland ventral lobe J:64981
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:153425
increased prostate intraepithelial neoplasia incidence J:191327, J:153425
Nogtm1Amc/Nog+
(involves: 129S1/Sv * C57BL/6J * ICR) 		decreased prostate gland ventral lobe weight J:130204
Nogtm1Amc/Nogtm1Amc
(involves: 129S1/Sv * C57BL/6J * ICR) 		abnormal prostate gland development J:130204
abnormal prostate gland morphology J:130204
Nr5a1tm2Klp/Nr5a1tm2.1Klp
Tg(Cga-cre)3Sac/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		prostate gland hypoplasia J:66593
Nr5a1tm2Klp/Nr5a1tm2Klp
Tg(Cga-cre)3Sac/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		prostate gland hypoplasia J:70412
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129X1/SvJ * C57BL/6) 		abnormal prostate gland epithelium morphology J:89350
Paip2tm1.2Nso/Paip2tm1.2Nso
Paip2btm1.2Nso/Paip2btm1.2Nso
(B6.129-Paip2btm1.2Nso Paip2tm1.2Nso) 		decreased prostate gland weight J:165272
Pdcd4tm1Yhcn/Pdcd4tm1Yhcn
(B6.129S6-Pdcd4tm1Yhcn) 		prostate gland cyst J:120583
Pgbd1em1(IMPC)Tcp/Pgbd1em1(IMPC)Tcp
(C57BL/6NCrl-Pgbd1em1(IMPC)Tcp/Tcp) 		enlarged prostate gland J:211773
Pik3catm1Jjz/Pik3catm1Jjz
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:138565
Piptm1Myal/Piptm1Myal
(involves: 129S/SvEv * C57BL/6) 		abnormal prostate gland dorsolateral lobe morphology J:202016
Plag1tm1Wjmv/Plag1tm1Wjmv
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		decreased prostate gland ventral lobe weight J:96846
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas) 		decreased prostate gland ventral lobe weight J:83246
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas) 		abnormal prostate gland epithelium morphology J:84352
increased prostate gland ventral lobe weight J:84352
Prlrtm1Cnp/Prlrtm1Cnp
Tg(C3-1-TAg)cJeg/0
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N) 		increased prostate intraepithelial neoplasia incidence J:84352
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd) 		abnormal prostate gland epithelium morphology J:106511
abnormal prostate gland morphology J:106511
decreased prostate gland weight J:106511
Pscatm1Witt/Psca+
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
increased prostate gland tumor incidence J:133908
increased prostate intraepithelial neoplasia incidence J:133908
Pscatm1Witt/Pscatm1Witt
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
increased prostate gland tumor incidence J:133908
increased prostate intraepithelial neoplasia incidence J:133908
Ptentm1.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased prostate gland tumor incidence J:158751
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * BALB/c) 		increased prostate gland tumor incidence J:110567
Ptentm1.1Hwu/Pten+
Tmprss2tm1.1(ERG)Sho/Tmprss2tm1.1(ERG)Sho
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:212219
Ptentm1.1Hwu/Pten+
Tmprss2tm2.1(ETV1)Sho/Tmprss2tm2.1(ETV1)Sho
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:212219
Ptentm1.2Mwst/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased prostate gland tumor incidence J:158751
Ptentm1Hwu/Pten+
Tg(ARR2/Pbsn-FGF8)3Prb/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		enlarged prostate gland J:106650
increased prostate gland adenocarcinoma incidence J:106650
increased prostate intraepithelial neoplasia incidence J:106650
prostate gland epithelial hyperplasia J:106650
Ptentm1Hwu/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:93902
Ptentm1Hwu/Pten+
Tmprss2tm2.1(ETV1)Sho/Tmprss2tm2.1(ETV1)Sho
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:212219
prostate gland cyst J:212219
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae) 		increased prostate gland adenocarcinoma incidence J:144810
increased prostate intraepithelial neoplasia incidence J:144810
Ptentm1Hwu/Ptentm1Hwu
Cop1tm2.1Vmd/Cop1tm2.1Vmd
Tg(Pbsn-cre)4Prb/0
(B6N.CgCop1tm2.1Vmd Ptentm1Hwu Tg(Pbsn-cre)4Prb) 		increased prostate gland adenocarcinoma incidence J:172653
increased prostate intraepithelial neoplasia incidence J:172653
Ptentm1Hwu/Ptentm1Hwu
Ptpn1tm1Bpk/Ptpn1tm1Bpk
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:231906
increased prostate intraepithelial neoplasia incidence J:231906
Ptentm1Hwu/Ptentm1Hwu
Rictortm1.1Mgn/Rictortm1.1Mgn
(involves: 129S4/SvJae * 129S6/SvEvTac) 		abnormal prostate gland duct morphology J:144810
abnormal prostate gland epithelium morphology J:144810
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-fat-1)1Jxk/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		decreased prostate gland weight J:124208
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-MYC,-GFP*)#Rugg/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2) 		increased prostate gland adenocarcinoma incidence J:261540
increased prostate intraepithelial neoplasia incidence J:261540
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp1-cre)1Jig/0
(involves: 129S4/SvJae * FVB/N) 		increased prostate gland tumor incidence J:106662
prostate gland anterior lobe hyperplasia J:106662
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:142106
increased prostate gland tumor incidence J:142106
increased prostate intraepithelial neoplasia incidence J:138565
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		enlarged prostate gland anterior lobe J:170965
increased prostate gland adenocarcinoma incidence J:268934, J:184935, J:212219
increased prostate gland tumor incidence J:268934, J:172730, J:170965
increased prostate gland weight J:170965
increased prostate intraepithelial neoplasia incidence J:268934, J:131932, J:212219
prostate gland hyperplasia J:170965
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		abnormal prostate gland epithelium morphology J:93902
abnormal prostate gland morphology J:124208
enlarged prostate gland J:93902
increased prostate gland adenocarcinoma incidence J:93902, J:124208
increased prostate gland tumor incidence J:124208
increased prostate gland weight J:124208
increased prostate intraepithelial neoplasia incidence J:93902, J:106650
prostate gland epithelial hyperplasia J:93902
prostate gland hyperplasia J:93902
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)20Fwan/?
(involves: 129S4/SvJae * C57BL/6 * FVB/NCrl) 		increased prostate gland adenocarcinoma incidence J:238768
increased prostate intraepithelial neoplasia incidence J:238768
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased prostate gland tumor incidence J:63478
Ptentm1Mro/Pten+
Tg(KLK3-cre)D4Trp/0
(involves: 129P2/OlaHsd * FVB) 		abnormal prostate gland epithelium morphology J:99524
increased prostate gland adenocarcinoma incidence J:99524
increased prostate gland tumor incidence J:99524
increased prostate gland weight J:99524
increased prostate intraepithelial neoplasia incidence J:99524
prostate gland hyperplasia J:99524
Ptentm1Mro/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:184533
Ptentm1Mro/Ptentm1Mro
Tg(KLK3-cre)D4Trp/0
(involves: 129P2/OlaHsd * FVB) 		prostate gland epithelial hyperplasia J:99524
Ptentm1Ppp/Pten+
Tg(Pbsn-TAg)15Tvd/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:103408
increased prostate gland tumor incidence J:103408
increased prostate intraepithelial neoplasia incidence J:103408
Ptentm1Ppp/Ptentm2Ppp
(involves: 129S1/Sv * C57BL/6) 		abnormal prostate gland morphology J:86212
increased prostate gland tumor incidence J:86212
prostate gland anterior lobe hyperplasia J:86212
prostate gland dorsolateral lobe hyperplasia J:86212
prostate gland epithelial hyperplasia J:86212
Ptentm1Rdp/Ptentm1Rdp
Smad4tm1Rdp/Smad4tm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm1Rdp/Tert+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
increased prostate intraepithelial neoplasia incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm1Rdp/Terttm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Terttm3Rdp/Terttm3Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
increased prostate intraepithelial neoplasia incidence J:186105
Ptentm1Rdp/Ptentm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:186105
increased prostate intraepithelial neoplasia incidence J:186105
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J) 		increased prostate intraepithelial neoplasia incidence J:53065
Ptentm1Rps/Pten+
(involves: 129S1/Sv * 129S1/SvImJ * C57BL/6J) 		abnormal prostate gland epithelium morphology J:75085
increased prostate intraepithelial neoplasia incidence J:75085
Ptentm1Rps/Pten+
RictorGt(RRR347)Byg/Rictor+
(involves: 129P2/OlaHsd * 129S1/Sv * BALB/c * C57BL/6) 		prostate gland hyperplasia J:144810
Ptentm2.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased prostate gland tumor incidence J:158751
Ptentm2.1Ppp/Pten+
Spry1tm1Jdli/Spry1tm1.1Jdli
Spry2tm1Mrt/Spry2tm1.1Mrt
Tg(Osr1-cre)4Mrt/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * FVB/N) 		increased prostate gland tumor incidence J:192348
increased prostate intraepithelial neoplasia incidence J:192348
Ptentm2.1Ppp/Ptentm2.1Ppp
Rb1tm2Brn/Rb1tm2Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:307910
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(CAG-Bgeo,-Spry2,-ALPP)1Mrt/0
Tg(Osr1-cre)4Mrt/0
(involves: 129P2/OlaHsd * 129S1/Sv * FVB/N) 		increased prostate intraepithelial neoplasia incidence J:192348
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Osr1-cre)4Mrt/0
(involves: 129S1/Sv * 129X1/SvJ) 		increased prostate intraepithelial neoplasia incidence J:192348
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		abnormal prostate gland epithelium morphology J:86212
abnormal prostate gland morphology J:86212
enlarged prostate gland J:86212
increased prostate gland adenocarcinoma incidence J:163589, J:100683
increased prostate gland tumor incidence J:86212, J:100683
increased prostate intraepithelial neoplasia incidence J:239660, J:163589, J:100683, J:200002
prostate gland epithelial hyperplasia J:86212, J:100683
prostate gland hyperplasia J:86212
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Pbsn-cre)8113ANg/0
(involves: 129S1/Sv * C57BL/6) 		abnormal prostate gland morphology J:86212
enlarged prostate gland J:86212
increased prostate gland tumor incidence J:86212
prostate gland epithelial hyperplasia J:86212
Ptentm2.1Ppp/Ptentm2.1Ppp
Trp53tm1Thl/Trp53tm1Thl
Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		increased prostate gland tumor incidence J:100683
Ptentm2Mak/Ptentm2Mak
Tg(KLK3-cre)13Saa/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:214242
increased prostate gland tumor incidence J:214242
increased prostate intraepithelial neoplasia incidence J:214242
Rargtm1Blt/Rargtm1Blt
(involves: 129P2/OlaHsd * C57BL/6J) 		squamous metaplasia of prostate gland J:27473
Rargtm1Ipc/Rargtm1Ipc
(involves: 129S2/SvPas) 		abnormal prostate gland morphology J:12691
squamous metaplasia of prostate gland J:12691
Rargtm3.1Ipc/Rargtm3.1Ipc
(involves: C57BL/6 * SJL) 		squamous metaplasia of prostate gland J:75133
Rln1tm1Wint/Rln1tm1Wint
(involves: 129S1/Sv * C57BL/6J) 		abnormal prostate gland development J:84575
abnormal prostate gland epithelium morphology J:84575
abnormal prostate gland morphology J:84575
small prostate gland J:84575
Rxratm1Krc/Rxra+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		abnormal prostate gland branching morphogenesis J:78553
increased prostate intraepithelial neoplasia incidence J:78553
prostate gland epithelial hyperplasia J:78553
Rxratm1Krc/Rxratm1Krc
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		abnormal prostate gland branching morphogenesis J:78553
increased prostate intraepithelial neoplasia incidence J:78553
Scribtm1.1Phum/Scribtm1.1Phum
Tg(Pbsn-cre)20Fwan/0
(involves: FVB/NCrl) 		increased prostate intraepithelial neoplasia incidence J:178461
prostate gland hyperplasia J:178461
Scribtm1.2Phum/Scrib+
(involves: FVB/N) 		increased prostate gland weight J:178461
prostate gland hyperplasia J:178461
Serpinf1tm1Craw/Serpinf1+
(involves: 129X1/SvJ * C57BL/6J) 		abnormal prostate gland morphology J:83748
prostate gland epithelial hyperplasia J:83748
Serpinf1tm1Craw/Serpinf1tm1Craw
(involves: 129X1/SvJ * C57BL/6J) 		abnormal prostate gland morphology J:83748
prostate gland epithelial hyperplasia J:83748
Sfrp1tm1Jrbn/Sfrp1tm1Jrbn
(involves: 129 * C57BL/6J) 		abnormal prostate gland branching morphogenesis J:136160
abnormal prostate gland morphology J:136160
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		increased prostate gland tumor incidence J:177486
Spry1tm1Jdli/Spry1tm1.1Jdli
Spry2tm1Mrt/Spry2tm1.1Mrt
Tg(Osr1-cre)4Mrt/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * FVB/N) 		increased prostate intraepithelial neoplasia incidence J:192348
prostate gland epithelial hyperplasia J:192348
Srd5a1tm1Mahe/Srd5a1tm1Mahe
Srd5a2tm1Mahe/Srd5a2tm1Mahe
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6J) 		small prostate gland J:72807
small prostate gland anterior lobe J:72807
Srd5a2tm1Mahe/Srd5a2tm1Mahe
(involves: 129S/SvEv * C57BL/6J) 		small prostate gland J:72807
small prostate gland anterior lobe J:72807
Startm1Klp/Startm1Klp
(involves: 129P2/OlaHsd) 		prostate gland hypoplasia J:43589
small prostate gland J:43589, J:64337
Stat5atm1Mam/Stat5atm1Mam
(involves: 129S6/SvEvTac) 		abnormal prostate gland epithelium morphology J:63495
prostate gland cyst J:63495
Tbx21tm1Glm/Tbx21tm1Glm
Tg(TRAMP)8247Ng/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:88093
increased prostate gland tumor incidence J:88093
increased prostate intraepithelial neoplasia incidence J:88093
Tg(ARR2/Pbsn-FGF8)3Prb/0
(involves: C57BL/6 * DBA/2) 		abnormal prostate gland morphology J:78918
increased prostate intraepithelial neoplasia incidence J:106650, J:78918
prostate gland hyperplasia J:106650, J:78918
Tg(Arr2/Pbsn-FGFR1K656E)1Wmck/0
(involves: FVB) 		increased prostate intraepithelial neoplasia incidence J:87067
Tg(Arr2/Pbsn-FGFR1K656E)1Wmck/0
Tg(Pbsn-FGFR2_iiib*)#Ng/0
(involves: FVB) 		increased prostate intraepithelial neoplasia incidence J:87067
Tg(ARR2/Pbsn-MYC)7Key/?
(involves: FVB/N) 		enlarged prostate gland J:223213
increased prostate gland adenocarcinoma incidence J:223213, J:85480
increased prostate gland tumor incidence J:85480
increased prostate intraepithelial neoplasia incidence J:223213, J:85480
Tg(C3-1-TAg)cJeg/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:52786, J:46513, J:72324
increased prostate intraepithelial neoplasia incidence J:46513, J:72324
prostate gland epithelial hyperplasia J:52786
Tg(C3-1-TAg)cJeg/0
(FVB/N-Tg(C3-1-TAg)cJeg) 		increased prostate gland tumor incidence J:84352
increased prostate intraepithelial neoplasia incidence J:84352
Tg(CAG-cat,-ALOX15)1868Klv/0
Tg(Pbsn-cre)4Prb/0
(involves: C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:114903
Tg(CAG-cat,-ALOX15)1868Klv/Tg(CAG-cat,-ALOX15)1868Klv
Tg(Pbsn-cre)4Prb/?
(involves: C57BL/6 * DBA/2) 		increased prostate intraepithelial neoplasia incidence J:114903
Tg(CAG-MYC,-GFP*)#Rugg/0
Tg(Pbsn-cre)4Prb/0
(involves: C57BL/6 * C57BL/6J * DBA/2) 		abnormal prostate gland morphology J:261540
Tg(Ggamma-T)15Cps/0
(involves: C57BL/6J * CBA/J) 		increased prostate gland tumor incidence J:38778
increased prostate intraepithelial neoplasia incidence J:38778
Tg(Ggamma-T)15Cps/Tg(Ggamma-T)15Cps
(involves: C57BL/6J * CBA/J) 		increased prostate gland tumor incidence J:38778
increased prostate intraepithelial neoplasia incidence J:38778
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727, J:184212
prostate gland hyperplasia J:206727, J:184212
Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps/0
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
Tg(KRT19-TAg)7Eps/0
(involves: FVB/N) 		increased prostate gland tumor incidence J:64395
prostate gland hyperplasia J:64395
Tg(Msmb-TAg)183-2Xuan/0
(involves: C57BL/6 * CBA) 		increased prostate gland adenocarcinoma incidence J:80313
increased prostate intraepithelial neoplasia incidence J:80313
prostate gland epithelial hyperplasia J:80313
Tg(Msmb-TAg)186-3Xuan/0
(involves: C57BL/6 * CBA) 		prostate gland epithelial hyperplasia J:80313
Tg(Pbsn-Ar*E231G)7353Ng/0
(involves: FVB/N) 		abnormal prostate gland epithelium morphology J:96117
abnormal prostate gland ventral lobe morphology J:96117
increased prostate gland adenocarcinoma incidence J:96117
increased prostate gland tumor incidence J:96117
prostate gland ventral lobe hyperplasia J:96117
Tg(Pbsn-Cdc37)1Stp/0
(involves: C57BL/6 * DBA/2 * ICR) 		abnormal prostate gland morphology J:93695
prostate gland epithelial hyperplasia J:93695
Tg(Pbsn-ERG*)1Vv/0
(involves: 129/Sv * C57BL/6J * CBA) 		abnormal prostate gland epithelium morphology J:131932
increased prostate intraepithelial neoplasia incidence J:131932
Tg(Pbsn-ERG*)1Vv/0
(involves: 129S1/SvImJ * C57BL/6J * CBA) 		increased prostate gland adenocarcinoma incidence J:222916
increased prostate gland tumor incidence J:222916
Tg(Pbsn-FGF7)3293Ng/0
(Not Specified) 		abnormal prostate gland duct morphology J:80821
abnormal prostate gland epithelium morphology J:80821
abnormal prostate gland morphology J:80821
increased prostate intraepithelial neoplasia incidence J:80821
prostate gland epithelial hyperplasia J:80821
prostate gland hyperplasia J:80821
Tg(Pbsn-FGFR1*K656E)#Wmck/0
(involves: FVB) 		enlarged prostate gland J:87519
increased prostate intraepithelial neoplasia incidence J:87519
prostate gland hyperplasia J:87519
Tg(Pbsn-FGFR1*K656E)#Wmck/0
Tg(Pbsn-FGFR2_iiib*)#Ng/0
(involves: FVB) 		increased prostate intraepithelial neoplasia incidence J:87067
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(FVB-Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp) 		increased prostate gland adenocarcinoma incidence J:130340
increased prostate gland tumor incidence J:130340
increased prostate intraepithelial neoplasia incidence J:130340, J:87092
prostate gland cyst J:130340
prostate gland hyperplasia J:87092
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
Tg(Pbsn-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		increased prostate gland adenocarcinoma incidence J:206727
Tg(Pbsn-FGFR2_iiib*)#Ng/0
(Not Specified) 		abnormal prostate gland duct morphology J:80821
abnormal prostate gland epithelium morphology J:80821
abnormal prostate gland morphology J:80821
small prostate gland J:80821
Tg(Pbsn-Hpn,-GFP)DVv/0
(involves: C57BL/6J * CBA) 		abnormal prostate gland morphology J:92562
Tg(Pbsn-Hpn,-GFP)DVv/0
Tg(Pbsn-Tag)12T7fRjm/0
(involves: C57BL/6J * CBA * CD-1) 		abnormal prostate gland morphology J:92562
enlarged prostate gland J:92562
increased prostate gland adenocarcinoma incidence J:92562
increased prostate intraepithelial neoplasia incidence J:92562
Tg(Pbsn-IGF1*)5305Ng/0
(involves: FVB/N) 		abnormal prostate gland epithelium morphology J:144539
abnormal prostate gland morphology J:144539
increased prostate intraepithelial neoplasia incidence J:144539
Tg(Pbsn-IGF1*)5305Ng/0
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * FVB/N) 		increased prostate gland tumor incidence J:144539
Tg(Pbsn-Lrp5/Fkbp1a,-luc*)#Dmps/0
(involves: FVB/N) 		prostate gland hyperplasia J:206727
Tg(Pbsn-MYC)6Key/?
(involves: FVB) 		increased prostate gland adenocarcinoma incidence J:85480
increased prostate gland tumor incidence J:85480
increased prostate intraepithelial neoplasia incidence J:85480
Tg(Pbsn-MYC)#Tt/?
(involves: C57BL/6J) 		abnormal prostate gland morphology J:205395
increased prostate gland adenocarcinoma incidence J:205395
increased prostate intraepithelial neoplasia incidence J:205395
Tg(Pbsn-SFRP1)1Pcma/0
(FVB/N-Tg(Pbsn-SFRP1)1Pcma) 		abnormal prostate gland morphology J:136160
Tg(Pbsn-Tag)12T7fRjm/0
(involves: CD-1) 		abnormal prostate gland morphology J:92562
enlarged prostate gland J:92562
increased prostate gland adenocarcinoma incidence J:48623
increased prostate gland tumor incidence J:48623
increased prostate intraepithelial neoplasia incidence J:92562, J:48623
prostate gland hyperplasia J:48623
Tg(Pbsn-Tag)12T10Rjm/0
(involves: CD-1) 		increased prostate gland adenocarcinoma incidence J:68483, J:48623
increased prostate gland tumor incidence J:48623
increased prostate intraepithelial neoplasia incidence J:68483
Tg(Pbsn-TAg)15Tvd/0
(involves: C57BL/6 * DBA/2) 		abnormal prostate gland epithelium morphology J:103408
increased prostate gland adenocarcinoma incidence J:103408
increased prostate intraepithelial neoplasia incidence J:103408
prostate gland epithelial hyperplasia J:103408
Tg(Pbsn-TAg)15Tvd/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		abnormal prostate gland epithelium morphology J:103408
Tg(Tcra,Tcrb)HRVAll/0
Tg(TRAMP)8247Ng/0
(B6.Cg-Tg(TRAMP)8247Ng Tg(Tcra,Tcrb)HRVAll) 		increased prostate gland tumor incidence J:131347
Tg(TRAMP)8247Ng/0
(involves: 129S1/Sv * C57BL/6) 		increased prostate gland tumor incidence J:108849
Tg(TRAMP)8247Ng/0
(involves: C57BL/6) 		increased prostate gland adenocarcinoma incidence J:217920, J:65303
prostate gland hyperplasia J:65303
Tg(TRAMP)8247Ng/0
(involves: C3H * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:125633
increased prostate gland tumor incidence J:125633
increased prostate gland weight J:125633
increased prostate intraepithelial neoplasia incidence J:125633
Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:133908
increased prostate gland tumor incidence J:133908
increased prostate intraepithelial neoplasia incidence J:133908, J:131932
Tg(TRAMP)8247Ng/0
Usp11tm1Tac/Y
(involves: 129 * C57BL/6) 		increased prostate gland adenocarcinoma incidence J:270214
increased prostate intraepithelial neoplasia incidence J:270214
Tgfb2tm1Doe/Tgfb2+
(involves: 129P2/OlaHsd * Black Swiss) 		prostate gland anterior lobe hyperplasia J:78547
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased prostate gland adenocarcinoma incidence J:204736
increased prostate intraepithelial neoplasia incidence J:204736
Thbs2em1(IMPC)Mbp/Thbs2em1(IMPC)Mbp
(C57BL/6NCrl-Thbs2em1(IMPC)Mbp/MbpMmucd) 		abnormal prostate gland morphology J:211773
enlarged prostate gland J:211773
Tmprss11atm1Dgen/Tmprss11atm1Dgen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		prostate gland hyperplasia J:175364
Tom1l2Gt(XG909)Byg/Tom1l2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased prostate gland tumor incidence J:133892
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		increased prostate gland tumor incidence J:133892
Trim9em1(IMPC)Ccpcz/Trim9em1(IMPC)Ccpcz
(C57BL/6N-Trim9em1(IMPC)Ccpcz/Ccpcz) 		abnormal prostate gland morphology J:211773
small prostate gland J:211773
Trp63tm1Fmc/Trp63tm1Fmc
(involves: 129S4/SvJae) 		abnormal prostate gland branching morphogenesis J:66126
absent prostate gland J:66126
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased prostate gland weight J:99980
Ulk3em2(IMPC)Tcp/Ulk3em2(IMPC)Tcp
(C57BL/6NCrl-Ulk3em2(IMPC)Tcp/Tcp) 		enlarged prostate gland J:211773
Upk1aem2Mgef/Upk1aem2Mgef
(C57BL/6NJNcbs-Upk1aem2Mgef) 		abnormal prostate gland epithelium morphology J:345207
abnormal prostate gland morphology J:345207
enlarged prostate gland J:345207
increased prostate gland weight J:345207
Usp11tm1Tac/Y
(involves: 129 * C57BL/6) 		enlarged prostate gland J:270214
prostate gland epithelial hyperplasia J:270214
Wdr77tm1Zwan/Wdr77+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal prostate gland epithelium morphology J:137003
prostate gland epithelial hyperplasia J:137003
prostate gland hyperplasia J:137003
Wdr77tm2Zwan/Wdr77tm2Zwan
Tg(Pbsn-cre)20Fwan/0
(involves: C57BL/6J * FVB/NCrl) 		abnormal prostate gland anterior lobe morphology J:162922
abnormal prostate gland branching morphogenesis J:162922
abnormal prostate gland development J:162922
abnormal prostate gland dorsolateral lobe morphology J:162922
abnormal prostate gland duct morphology J:162922
abnormal prostate gland epithelium morphology J:162922
abnormal prostate gland ventral lobe morphology J:162922
decreased prostate gland duct number J:162922
prostate gland epithelial hyperplasia J:162922
small prostate gland J:162922
Zfhx3tm1.1Jtd/Zfhx3tm1.1Jtd
Tg(Pbsn-cre)4Prb/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL) 		increased prostate intraepithelial neoplasia incidence J:189563
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/17/2024
MGI 6.24 		The Jackson Laboratory